Sort
23,748 grants matching “melanoma”
GENETIC INSTABILITY AND THE CELL CYCLE
$248,412University Of Washington · P01 · FY2002 · CA
GENETIC INSTABILITY AND THE CELL CYCLE
$248,412University Of Washington · P01 · FY2001 · CA
Intravesical rF-GMCSF and rF-TRICOM in the treatment of advanced bladder cancer
$248,411Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2006 · CA
Electroporation Based Cytokine Gene Therapy for Melanoma
$248,376Ichor Medical Systems, Inc. · R43 · FY2002 · CA
MEMORIAL HOSPITAL AND CANCER AND ACUTE LEUKEMIA GROUP B
$248,374Sloan-Kettering Institute For Cancer Res · U10 · FY2002 · CA
Role of Immune Regulatory Pathways in BRAF Targeted Therapy In Melanoma
$248,370Arlene H Sharpe · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
In Vivo Imaging Facility
$248,336Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · CA
Biorepository and Molecular Pathology (BMP)
$248,332Gary Christopher Fillmore · University Of Utah · P30 · FY2024 · CA
Biorepository and Molecular Pathology (BMP)
$248,278Gary Christopher Fillmore · University Of Utah · P30 · FY2021 · CA
Biorepository and Molecular Pathology (BMP)
$248,276Gary Christopher Fillmore · University Of Utah · P30 · FY2020 · CA
CIRCADIAN REGULATION OF INNATE IMMUNE MECHANISMS OF VIRAL RECOGNITION
$248,250Erol Fikrig · Yale University · R21 · FY2009 · AI
Isolation of novel tumor antigens
$248,249Mirus Bio Corporation · R43 · FY2003 · CA
A New Strategy for Targeted Chemoimmunotherapy of Cancer
$248,198University Of Pittsburgh At Pittsburgh · R01 · FY2003 · CA
Small Molecule Enhancers of Photodynamic Therapy for Skin Cancer
$248,163Edward V. Maytin · Massachusetts General Hospital · P01 · FY2011 · CA
Development of an a MC1R selective companion diagnostic imaging probe
$248,155Jose Gabriel Garcia · Modulation Therapeutics, Inc. · R43 · FY2018 · CA
MATCHMAKERS - Solving TCR recognition and design via integrated high-throughput screening, structural, functional, and computational approaches
$248,155Nikolaos Sgourakis · Children'S Hosp Of Philadelphia · OT2 · FY2024 · CA
Administrative Core
$248,113Peter Karl Sorger · Harvard Medical School · U54 · FY2018 · CA
Validation of circulating tumor DNA assays for detection of metastatic melanoma
$248,101David Polsky · New York University School Of Medicine · UH2 · FY2017 · CA
Melanoma Therapy via peptide targeted alpha-radiation
$248,059Alphamed, Inc · R42 · FY2002 · CA
Building an in-vivo gene regulatory network for melanocyte stem cell maintenance.
$248,053Melissa L Harris · University Of Alabama At Birmingham · R00 · FY2017 · AG
Determination of Clinical Feasibility of EPR Oximetry of Tumors
$248,032Harold M Swartz · Dartmouth College · R21 · FY2007 · CA
CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER
$247,975James P Allison · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA
Cellular Responses to Environmental Insults and Risk for Melanoma Development
$247,886Marila Cordeiro-Stone · Univ Of North Carolina Chapel Hill · R01 · FY2010 · ES
Combinatorial Approaches to Overcoming Resistance to BRAF(V600E) Targeted Thera
$247,819David E Fisher · Massachusetts General Hospital · P01 · FY2017 · CA
Administrative Core
$247,744John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA